Company Filing History:
2 out of 7 
1 out of 850 
Years Active: 2003-2014
Title: Martin Hepper: Innovator in Antibody Effectiveness and Blood Treatment
Introduction
Martin Hepper is a notable inventor based in Neustadt, Germany. He has made significant contributions to the field of medical technology, particularly in enhancing the effectiveness of antibodies and developing methods for blood treatment. With a total of three patents to his name, Hepper's work has the potential to impact patient care significantly.
Latest Patents
Hepper's latest patents include innovative methods aimed at increasing the effectiveness of antibodies and Fcγ receptor-binding active ingredients. One of his inventions describes an ex vivo method that involves preparing a blood sample from a patient, subjecting it to immunoapheresis, and then administering a therapeutically effective antibody or Fcγ receptor-binding active ingredient. Another patent focuses on a process for manufacturing an adsorbent designed to reduce the concentration of fibrinogen and/or fibrin in blood or blood plasma. This process involves activating a carrier material, preferably a copolymer derived from (meth)acrylates and/or (meth)acrylic acid amides, followed by thermal treatment at elevated temperatures.
Career Highlights
Throughout his career, Martin Hepper has worked with prominent companies in the medical field, including Fresenius Hemocare GmbH and Fresenius Medical Care Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Hepper has collaborated with notable colleagues such as Hans-Peter Leinenbach and Veit Otto. These partnerships have likely facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.
Conclusion
Martin Hepper's contributions to the field of medical technology through his patents and collaborations highlight his role as an innovator. His work in improving antibody effectiveness and blood treatment methods showcases the potential for advancements in patient care.